TRUL Stock Overview
Operates as a cannabis retailer. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Trulieve Cannabis Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$8.87 |
| 52 Week High | CA$20.00 |
| 52 Week Low | CA$6.31 |
| Beta | 1.47 |
| 11 Month Change | -48.10% |
| 3 Month Change | -33.11% |
| 1 Year Change | 12.85% |
| 33 Year Change | -76.44% |
| 5 Year Change | -45.42% |
| Change since IPO | -11.12% |
Recent News & Updates
Recent updates
Are Investors Undervaluing Trulieve Cannabis Corp. (CSE:TRUL) By 47%?
Sep 04
Trulieve Cannabis Corp.'s (CSE:TRUL) 28% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
Jun 15Trulieve Cannabis Corp.'s (CSE:TRUL) CEO Will Probably Struggle To See A Pay Rise This Year
Jun 06Are Investors Undervaluing Trulieve Cannabis Corp. (CSE:TRUL) By 38%?
May 01Revenues Not Telling The Story For Trulieve Cannabis Corp. (CSE:TRUL) After Shares Rise 26%
Mar 31Is Trulieve Cannabis (CSE:TRUL) A Risky Investment?
Feb 15There's Reason For Concern Over Trulieve Cannabis Corp.'s (CSE:TRUL) Massive 29% Price Jump
Jan 16Calculating The Intrinsic Value Of Trulieve Cannabis Corp. (CSE:TRUL)
Mar 06These 4 Measures Indicate That Trulieve Cannabis (CSE:TRUL) Is Using Debt Extensively
Jan 26Does Trulieve Cannabis (CSE:TRUL) Have A Healthy Balance Sheet?
Aug 07Are Trulieve Cannabis Corp. (CSE:TRUL) Investors Paying Above The Intrinsic Value?
Jul 03These 4 Measures Indicate That Trulieve Cannabis (CSE:TRUL) Is Using Debt Reasonably Well
Mar 21Is Trulieve Cannabis (CSE:TRUL) Using Too Much Debt?
Aug 16Shareholder Returns
| TRUL | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | -9.5% | -6.1% | 0.7% |
| 1Y | 12.8% | -22.3% | 21.7% |
Return vs Industry: TRUL exceeded the Canadian Pharmaceuticals industry which returned -22.3% over the past year.
Return vs Market: TRUL underperformed the Canadian Market which returned 21.7% over the past year.
Price Volatility
| TRUL volatility | |
|---|---|
| TRUL Average Weekly Movement | 16.1% |
| Pharmaceuticals Industry Average Movement | 11.5% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.6% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: TRUL's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: TRUL's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1940 | 5,400 | Kim Rivers | www.trulieve.com |
Trulieve Cannabis Corp., together with its subsidiaries, operates as a cannabis retailer. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery. It sells flowers, edibles, vapes, creams, balms, salves, lotions, vaporizers, batteries, cartridge, concentrates, topicals, capsules, synringes, tinctures, and accessories under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, Trekkers, and Roll One brands.
Trulieve Cannabis Corp. Fundamentals Summary
| TRUL fundamental statistics | |
|---|---|
| Market cap | CA$1.62b |
| Earnings (TTM) | -CA$176.09m |
| Revenue (TTM) | CA$1.64b |
1.0x
P/S Ratio-9.6x
P/E RatioIs TRUL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TRUL income statement (TTM) | |
|---|---|
| Revenue | US$1.17b |
| Cost of Revenue | US$489.74m |
| Gross Profit | US$682.58m |
| Other Expenses | US$808.53m |
| Earnings | -US$125.95m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.66 |
| Gross Margin | 58.22% |
| Net Profit Margin | -10.74% |
| Debt/Equity Ratio | 36.9% |
How did TRUL perform over the long term?
See historical performance and comparison